News

Why It Makes Sense To Buy Eli Lilly Stock At $840
The trial met its primary objectives, showing the pill’s effectiveness in helping patients with Type 2 diabetes achieve ...
Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide
Lilly shares are up 14.2% in response to the news, while shares of its rivals in the GLP-1 weight loss market, Novo Nordisk ( ...
Why Eli Lilly and Company (LLY) Is Among the Best Blue Chip Stocks to Buy According to Billionaires
We recently published a list of 15 Best Blue Chip Stocks to Buy According to Billionaires. In this article, we are going to ...
UnitedHealth tumbles, Eli Lilly climbs, TSMC holds outlook
On today's Market Minute, Madison Mills takes a closer look at the top stories on Wall Street. UnitedHealth Group (UNH) stock ...
Where Will Eli Lilly Be in 5 Years?
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Is Eli Lilly and Company (LLY) the Best Low Volatility Stock to Buy Now?
We recently published a list of 10 Best Low Volatility Stocks to Buy Now. In this article, we are going to take a look at ...
Eli Lilly says GLP-1 pill for diabetes and weight loss effective in study, plans to seek FDA approval
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...